Gary Mathias
Co-Founder and Chief Executive Officer
Drugs similar to existing therapies
Thetis Pharmaceuticals LLC
United States of America
Biography
Mr. Mathias has more than 25 years of experience in the healthcare industry as an entrepreneur, investor and banker. For 15 years prior to joining Thetis full-time as CEO, Mathias was a senior partner at Carter Morse & Mathias, a boutique investment banking firm based in Southport, Connecticut. He previously was a senior vice president in the Healthcare Group at GE Equity Capital, Chief Operating Officer of Diabetes Support Systems, and executive vice president of Premier Healthcare, an healthcare focused private equity firm. Mr. Mathias has an MBA from the Yale School of Management, a BA in Economics from Harvard College, and was a Fulbright Fellow in economic development.
Research Interest
Novel small molecule drugs to treat inflammatory bowel disease (IBD) based on a unique paradigm of resolving inflammation
